Newsletter
Imagine a world where the most challenging targets in cancer treatment become accessible. The MYC transcription factor, implicated in over 70% of human cancers, has been notoriously difficult to target due to its disordered structure and fast turnover rate. But now, a new generation of peptide libraries is changing the
Newsletter
Are you curious about the latest breakthroughs in COVID-19 treatment? Paxlovid, a promising antiviral therapy, has garnered attention for its potential to reduce hospitalization and death risks. In our battle against COVID-19, effective treatments are crucial, and Paxlovid shines as a beacon of hope. Delve into its efficacy, side effects,
Newsletter
and what’s going on in Australia
Newsletter
Arthritis is a prevalent and diverse condition that impacts millions of people worldwide. It occurs when the joints, which are the connections between bones, become inflamed, resulting in pain, stiffness, and reduced mobility. Over 100 different types of arthritis have been identified, often associated with other musculoskeletal disorders, each presenting
Healthcare & Innovations
The new frontier in cortisol and glucose monitoring